Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.
Sanem Pinar UysalYadi LiNicolas R ThompsonAlex MilinovichJustin R AbbatemarcoJeffrey A CohenDevon S ConwayDaniel OntanedaJohn A MorrenSean J PittockPublished in: Annals of clinical and translational neurology (2024)
In this retrospective longitudinal study of CV2/CRMP5-IgG PND, patients with CNS involvement, particularly myelopathy, had higher probability of disability. SCLC was the main determinant of survival in this population.